Clinical nephrology-epidemiology-clinical trials: Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients

Kidney International

Volumn 62, Issue 5, 2002, Pages 1732-1742

  Hauer, Herbert A ^{a,b,c,d,e,f,g,h}   Bajema, Ingeborg M ^{a,b,c,d,e,f,g,h}   Van Houwelingen, Hans C ^{a,b,c,d,e,f,g,h}   Ferrario, Franco ^{a,b,c,d,e,f,g,h}   Noël, Laure Hélène ^{a,b,c,d,e,f,g,h}   Waldherr, Rüdiger ^{a,b,c,d,e,f,g,h}   Jayne, David R W ^{a,b,c,d,e,f,g,h}   Rasmussen, Niels ^{a,b,c,d,e,f,g,h}   Bruijn, Jan A ^{a,b,c,d,e,f,g,h}   Hagen, E Christiaan ^{a,b,c,d,e,f,g,h}   Rasmussen, N ^h   Neumann, I ^i,j   Mad Houn, P ^k   Sennesael, J ^l   Tesar, V ^m   Rychlik, I ^m   Bartunkova, J ^m   Luk, J ^m   Juhl, B Ravn ^h   Petersen, J ^h   Andersen, C B ^h   Szpirt, W ^h   Wiik, A ⁿ   Lokkegaard, H ^o   Nielsen, H ^o   Ring, T ^p   Sorensen, S Freiesleben ^q   Bacon, P A ^r   Exley, A ^r   Savage, C O S ^r   Gaskin, G ^s   Pusey, C ^s   Lockwood, C M ^g   Luq Mani, R ^t   Gronhagen Riska, C ^u   Ekstrand, A ^u   Guillevin, L ^v   Lhote, F ^v   Lesavre, P ^e   Noel, L H ^e   Landais, P ^e   Vanhille, P ^w   Bataille, P ^x   Esnault, V ^y   Woude, F Van Der ^z   Waldherr, R ^z   Schmitt, W ^z   Andrassy, K ^z   Hergesell, O ^z   Nowack, R ^z   Groot, K De ^aa   Herlyn, K ^aa   Gross, W L ^aa   Boki, K A ^ab   Boletis, J N ^ab   Emmanouel, D S ^ac   Feighery, C ^ad   Ferra Rio, Y ^d   Sinico, R A ^d   Gregorini, G ^ae   Dadoniene, J ^af   Hagen, E C ^c   Kallenberg, C G M ^ag   Stegeman, C ^ag   Tervaert, J W Cohen ^ah   Verburgh, C A ^a   Siegert, C E H ^a   Bruijn, J A ^a   Hauer, H A ^a   Hermans, J ^a   Houwelingen, J C Van ^a   Vergunst, C E ^a   Gurp, E Van ^ai   Bajema, I M ^b   Vasconcelos, C ^aj   Mirapeix, E ^ak   Sole, M ^ak   Petterson, E E ^al   Bruchfeld, A ^al   Westman, K W A ^am   Heigl, Z ^al   Chizzolini, C ^an   MacLahan, D ^ao   Depierreux, M ^ap   van Damme, B ^aq   Stejskalova, A ^m   Vernerova, Z ^m   Tornroth, T ^ar   Feller, A C ^as   Gaffney, E ^ad   Tardanico, R ^at   Consalonieri, R ^au   Garibotto, G ^av   Tiebosch, A T M G ^ag   Kooijman, C D ^c   Arques, M S ^ak   Algaba, F ^aw   Carreras, M ^ax   Perez, M Vaquero ^ay   Bernardo, L ^az   Sundelin, B ^al   Alm, P ^am   Wernersson, A ^al   Veress, B ^am   Landells, W ^ba   Howie, A J ^r   Fleming, S ^bb   Griffith, A P ^bc   Furness, P N ^bd   Cook, H T ^s   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c EEMLAND HOSPITAL   (Netherlands)

^d SAN CARLO BORROMEO HOSPITAL   (Italy)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h Rigshospitalet   (Denmark)

ⁱ WilhelminaHospital   (Austria)

^j ERASME HOSPITAL   (Belgium)

^k Institut Medical Edith Cavell   (Belgium)

^l FREE UNIVERSITY OF BRUSSELS   (Belgium)

^m CHARLES UNIVERSITY   (Czech Republic)

ⁿ STATENS SERUM INSTITUT   (Denmark)

^o GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^p AALBORG UNIVERSITY HOSPITAL   (Denmark)

^q BISPEBJERG HOSPITAL   (Denmark)

^r UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^s HAMMERSMITH HOSPITAL   (United Kingdom)

^t WESTERN GENERAL HOSPITAL   (United Kingdom)

^u HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^v AVICENNE HOSPITAL   (France)

^w CENTRE HOSPITALIER DE VALENCIENNES   (France)

^x Centre Hospitalier General   (France)

^y HÔTEL DIEU   (France)

^z UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^aa Rheumaklinik Bad Bramstedt   (Germany)

^ab LAIKO GENERAL HOSPITAL   (Greece)

^ac UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^ad ST JAMES S HOSPITAL   (Ireland)

^ae Spedale Civili   (Italy)

^af VILNIUS UNIVERSITY   (Lithuania)

^ag UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ah MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^ai UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^aj HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^ak HOSPITAL CLÍNIC   (Spain)

^al KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^am LUND UNIVERSITY HOSPITAL   (Sweden)

^an GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^ao UNIVERSITY HOSPITAL BASEL   (Switzerland)

^ap UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^aq UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ar UNIVERSITY OF HELSINKI   (Finland)

^as UNIVERSITY OF LÜBECK   (Germany)

^at Civili Hospital   (Italy)

^au FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^av ISUL   (Italy)

^aw Academic Hospital of the Free University ^*  (Spain)

^ax HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^ay HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^az HOSPITAL JOSEP TRUETA   (Spain)

^ba ST HELIER HOSPITAL   (United Kingdom)

^bb UNIVERSITY OF EDINBURGH   (United Kingdom)

^bc MORRISTON HOSPITAL   (United Kingdom)

^bd Leicester City Psychology Service   (United Kingdom)

more..

Author keywords

ANCA associated vasculitis; Microscopic polyangiitis; Pauci immune crescentic necrotizing glomerulonephritis; Renal biopsy; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOLOGY; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SAMPLE SIZE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS; ATROPHY; CORRELATION ANALYSIS; DEATH; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY NECROSIS; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RELAPSE;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AZATHIOPRINE; BIOPSY; CYCLOPHOSPHAMIDE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SAMPLE SIZE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 18644382821     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00605.x     Document Type: Article

References (35)

1. Petterson E, Sundelin B, Heigl Z: Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 43:141-149, 1995
2. Falk RJ, Jennette JC: ANCA small-vessel vasculitis. J Am Soc Nephrol 8:314-322, 1997
3. Bajema IM, Hagen EC, van der Woude FJ, Bruijn JA: Wegener's granulomatosis: A meta-analysis of 349 literary case reports. J Lab Clin Invest 129:17-22, 1997
4. Hauer HA, Bajema IM, van Houwelingen HC, et al: Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups. Kidney Int 61:80-89, 2002
5. Hogan SL, Nachman PH, Wilkman AS, et al: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23-32, 1996
6. Fauci AS, Haynes B, Katz P: The spectrum of vasculitis: Clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 89:660-676, 1978
7. Hoffman GS, Kerr GS, Leavitt RY, et al: Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 116:488-498, 1992
8. Savage COS, Harper L, Any D: Primary systemic vasculitis. Lancet 349:553-558, 1997
9. Serra A, Cameron JS, Turner DR, et al: Vasculitis affecting the kidney: Presentation, histopathology and long-term outcome. Quart J Med 53:181-207, 1984
10. Savage COS, Winearls CG, Evans DJ, et al: Microscopic polyarteritis: Presentation, pathology and prognosis. Quart J Med 220:467-483, 1985
11. Weiss MA, Crissman JD: Segmental necrotizing glomerulonephritis: Diagnostic, prognostic, and therapeutic significance. Am J Kidney Dis 6:199-211, 1985
12. Furlong TJ, Ibels LS, Eckstein RP: The clinical spectrum of necrotizing glomerulonephritis. Medicine (Baltimore) 66:192-201, 1987
13. Croker BP, Lee T, Gunnells JC: Clinical and pathologic features of polyarteritis nodosa and its renal-limited variant: Primary crescentic and necrotizing glomerulonephritis. Hum Pathol 18:38-44, 1987
14. Andrassy K, Erb A, Koderisch J, et al: Wegener's granulomatosis with renal involvement: Patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 35:139-147, 1991
15. Gans RO, Kuizinga MC, Goldschmeding R, et al: Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies. Nephron 64:182-188, 1993
16. Franssen CFM, Stegeman CA, Oost-Kort WW, et al: Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 9:1915-1923, 1998
17. Bajema IM, Hagen EC, Herons J, et al: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56:1751-1758, 1999
18. Jayne DRW, Rasmussen N: Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 72:737-747, 1997
19. Bajema IM, Hagen EC, Hansen BE, et al: The renal histopathology in systemic vasculitis: An international survey study of interand intra-observer agreement. Nephrol Dial Transplant 11:1989-1995, 1996
20. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
21. Luqmani RA, Bacon PA, Moots GJ, et al: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Quart J Med 87:671-678, 1994
22. Levey AS, Lan SP, Corwin HL, et al: Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116:114-123, 1992
23. Peters DK, Rees AJ, Lockwood CM, Pusey CD: Treatment and prognosis in antibasement membrane antibody-mediated nephritis. Transplant Proc 14:513-521, 1982
24. Senn S, Stevens L, Chaturvedi N: Repeated measures in clinical trials: Simple strategies for analysis using summary measures. Stat Med 19:861-877, 2000
25. Aasarod K, Iversen BM, Hammerstrom J, et al: Wegener's granulomatosis: Clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 15:611-618, 2000
26. Westman KW, Bygren PG, Olsson H, et al: Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9:842-852, 1998
27. Briedigkeit L, Kettritz R, Gobel U, Natusch R: Prognostic factors in Wegener's granulomatosis. Postgrad Med J 69:856-861, 1993
28. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY: Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 7:2271-2278, 1996
29. Downer G, Phan SH, Wiggins RC: Analysis of renal fibrosis in a rabbit model of crescentic nephritis. J Clin Invest 82:998-1006, 1988
30. Pirani CL: Evaluation of kidney biopsy specimens (chapt 4), in Renal Pathology With Clinical and Functional Correlations (2nd ed), edited by Tisher CC, Brenner BM, Philadelphia, J.B. Lippincott, 1994, p 85
31. Hauer HA, Bajema IM, de Heer E, et al: Distribution of renal lesions in idiopathic systemic vasculitis: A three-dimensional analysis of 87 glomeruli. Am J Kidney Dis 36:257-265, 2000
32. Ferrario F, Rastaldi MP: Pathology of rapidly progressive glomerulonephritis (chapt 4), in Rapidly Progressive Glomerulonephritis, edited by Pusey C, Rees AJ, Oxford, Oxford University Press, 1998, pp 59-100
33. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652-659, 1982
34. Hostetter TH, Olson JL, Rennke HG, et al: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
35. Jayne D, Rasmussen N, Andrassy K, et al, for the European Vasculitis Studygroup (EUVAS): Randomised Trial of Cyclophosphamide Versus Azathioprine as Remission Therapy for ANCA-associated Vasculitis (CYCAZAREM). (manuscript submitted for publication)